Covid-19: Johnson & Johnson delays vaccine rollout in Europe
Vaccine maker announces decision amid US probe into rare blood clots.
Johnson & Johnson says it is delaying the rollout of its coronavirus vaccine in Europe amid a U.S. probe into rare blood clots.
The company announced the decision Tuesday after regulators in the United States said they were recommending a “pause” in administration of the single-dose shot to investigate reports of potentially dangerous blood clots.
“We have been reviewing these cases with European health authorities,” the company said.
“We have made the decision to proactively delay the rollout of our vaccine in Europe.”
Hundreds of thousands of doses of the vaccine were due to be shipped to Europe in the coming weeks.
The youths filmed themselves walking at a mall without masks and... READ MORE
Students and staff must strictly adhere to all Covid safety protocols. READ MORE
Of all the 11 cases of the B.1.1.7 variant which was first detected... READ MORE
The kingdom will ensure the health and safety of pilgrims and enable... READ MORE
The city is one of the fastest to regain public transport ridership... READ MORE
Here's all you need to know about this employment law. READ MORE
If a man impersonates a woman to enter a place where only women are... READ MORE
It was asserted that Covid vaccine passports were the only way to... READ MORE